Bicistronic Construct for Optogenetic Prosthesis of Ganglion Cell Receptive Field of Degenerative Retina
- Authors: Petrovskaya L.E.1,2, Roshchin M.V.3, Smirnova G.R.3, Kolotova D.E.3,4, Balaban P.M.3, Ostrovsky M.A.4,5, Malyshev A.Y.3
-
Affiliations:
- Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation
- Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
- Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
- Faculty of Biology, Moscow State University
- Emanuel Institute of Biochemical Physics, Russian Academy of Sciences
- Issue: Vol 486, No 1 (2019)
- Pages: 184-186
- Section: Biochemistry, Biophysics, and Molecular Biology
- URL: https://journal-vniispk.ru/1607-6729/article/view/213001
- DOI: https://doi.org/10.1134/S1607672919030062
- ID: 213001
Cite item
Abstract
To perform optogenetic prosthetics of the retinal ganglion cell receptive field, a bicistronic genetic construct carrying the genes encoding the excitatory (channelrhodopsin-2) and inhibitory (Guillardia theta anion channelrhodopsin GtACR2) rhodopsins was created. A characteristic feature of this construct was the combination of these two genes with a mutant IRES insertion between them, which ensures the exact ratio of expression levels of the first and second genes in each transfected cell. Illumination of the central part of the neuron with light with a wavelength of 470 nm induced the action potential generation in the cell. Stimulation of the peripheral neuronal region with light induced the inhibition of action potential generation. Thus, using optogenetics methods, we simulated the ON–OFF interaction in the retinal ganglion cell receptive field. Theoretically, this construct can be used for optogenetic prosthetics of degenerative retina in the case of its delivery to the ganglion cells with lentiviral vectors.
About the authors
L. E. Petrovskaya
Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation; Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
Email: malyshev@ihna.ru
Russian Federation, Moscow, 117997; Moscow, 117997
M. V. Roshchin
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
Email: malyshev@ihna.ru
Russian Federation, Moscow, 117485
G. R. Smirnova
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
Email: malyshev@ihna.ru
Russian Federation, Moscow, 117485
D. E. Kolotova
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences; Faculty of Biology, Moscow State University
Email: malyshev@ihna.ru
Russian Federation, Moscow, 117485; Moscow, 119234
P. M. Balaban
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
Email: malyshev@ihna.ru
Russian Federation, Moscow, 117485
M. A. Ostrovsky
Faculty of Biology, Moscow State University; Emanuel Institute of Biochemical Physics, Russian Academy of Sciences
Email: malyshev@ihna.ru
Russian Federation, Moscow, 119234; Moscow, 119334
A. Y. Malyshev
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
Author for correspondence.
Email: malyshev@ihna.ru
Russian Federation, Moscow, 117485
Supplementary files
